<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-K FOR THE PERIOD ENDED MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 12-MOS <FISCAL-YEAR-END> MAR-31-2000 <PERIOD-START> APR-01-1999 <PERIOD-END> MAR-31-2000 <CASH> 11,553 <SECURITIES> 36,027 <RECEIVABLES> 24,237 <ALLOWANCES> 420 <INVENTORY> 34,542 <CURRENT-ASSETS> 111,607 <PP&E> 66,351 <DEPRECIATION> 46,683 <TOTAL-ASSETS> 131,275 <CURRENT-LIABILITIES> 30,939 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 12 <OTHER-SE> 98,973 <TOTAL-LIABILITY-AND-EQUITY> 131,275 <SALES> 163,567 <TOTAL-REVENUES> 163,567 <CGS> 129,998 <TOTAL-COSTS> 129,998 <OTHER-EXPENSES> 22,488<F1> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 473 <INCOME-PRETAX> (5,793) <INCOME-TAX> 30 <INCOME-CONTINUING> (5,823) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (5,823) <EPS-BASIC> (0.56) <EPS-DILUTED> (0.56)<F2><FN> <F1> Item consists of research and development. <F2> Item consists of basic earnings per share. </FN>